Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery Abhinav Goyal, MD, MHS, John H. Alexander,

Slides:

Advertisements

Similar presentations

Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program Olaf Reinhartz, MD, Katsuhide Maeda, MD, Bruce A. Reitz, MD,

Advertisements

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

Results of Coronary Artery Endarterectomy and Coronary Artery Bypass Grafting for Diffuse Coronary Artery Disease Srikrishna Sirivella, MD, Isaac Gielchinsky,

Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year.

Factors Influencing Hospital Length of Stay After Robotic Totally Endoscopic Coronary Artery Bypass Grafting Jeffrey D. Lee, MD, Nikolaos Bonaros, MD,

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

What Predicts Long-Term Survival After Heart Transplantation

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

Elevated Hemoglobin A1c Is Associated With Lower Socioeconomic Position and Increased Postoperative Infections and Longer Hospital Stay After Cardiac.

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Jeevan Nagendran, MD, Colleen M. Norris, PhD, Michelle M

Robert L. Smith, MD, Morley A. Herbert, PhD, Todd M

Elizabeth L. Nichols, MS, Jock N. McCullough, MD, Cathy S

Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD,

James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H

Elevated Preoperative Hemoglobin A1c Level is Associated With Reduced Long-Term Survival After Coronary Artery Bypass Surgery Michael E. Halkos, MD,

The Society of Thoracic Surgeons Thoracic Surgery Practice and Access Task Force: 2014 Workforce Report John S. Ikonomidis, MD, PhD The Annals of Thoracic.

Lindsay C.H. John, MD, FRCS The Annals of Thoracic Surgery

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Impact of Preoperative Angiotensin-Converting Enzyme Inhibitor Use on Clinical Outcomes After Cardiac Surgery Maral Ouzounian, MD, Karen J. Buth, MS,

Why surgery won the SYNTAX trial and why it matters

Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting Heng Zhang, MD, Xin Yuan, MD, PhD, Ruben.

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012 David.

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients David C. Chang, PhD,

Impact of Extracardiac Vascular Disease on Vein Graft Failure and Outcomes After Coronary Artery Bypass Surgery Ralf E. Harskamp, MD, John H. Alexander,

Surgical Resection of a Giant Coronary Aneurysm

Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.

Established Preoperative Risk Factors Do Not Predict Long-Term Survival in Isolated Coronary Artery Bypass Grafting Patients Giovanni Filardo, PhD, MPH,

Factors Influencing Hospital Length of Stay After Robotic Totally Endoscopic Coronary Artery Bypass Grafting Jeffrey D. Lee, MD, Nikolaos Bonaros, MD,

Radial Artery Grafts in Women: Utilization and Results

Origins of the Cardiothoracic Surgery Network (CTSNet)

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Predictors of Low Cardiac Output Syndrome After Isolated Coronary Artery Bypass Surgery: Trends Over 20 Years Khaled D. Algarni, MD, MHS, Manjula Maganti,

Thomas Bruce Ferguson, MD, May 6, 1923–May 26, 2013

Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Meta-Analysis of Medium and Long-Term Efficacy of Loading Statins After Coronary Artery Bypass Grafting Cheng Bin, MM, Mu Junsheng, MD, Zhang Jianqun,

Outcomes of early extubation after bypass surgery in the elderly

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Terry Shih, MD, Justin B. Dimick, MD, MPH

Impact of Residency Status on Perfusion Times and Outcomes for Coronary Artery Bypass Graft Surgery Constance K. Haan, MD, Sarah Milford-Beland, MS,

Statin in Combination With β-Blocker Therapy Reduces Postoperative Stroke After Coronary Artery Bypass Graft Surgery Denis Bouchard, MD, Michel Carrier,

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Invited Commentary The Annals of Thoracic Surgery

Robert Lee Replogle, September 30, 1931–May 9, 2016

Digital Drainage System Reduces Hospitalization After Video-Assisted Thoracoscopic Surgery Lung Resection Daniel L. Miller, MD, Gerald A. Helms, MD,

Charles T. Bakhos, MD, MS, Sidhu P. Gangadharan, MD, Graham M

On-Pump Versus Off-Pump Surgical Revascularization for Left Main Stem Stenosis: Risk Adjusted Outcomes John C.Y. Lu, Antony D. Grayson, BS, D. Mark Pullan

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Christoph P. Hornik, MD, Xia He, MS, Jeffrey P. Jacobs, MD, Jennifer S

Stephen A. Olenchock, DO, Dimitri Karmpaliotis, MD, William J

Secondary prevention after coronary bypass: the American Heart Association “Get with the Guidelines” program Timothy A Denton, MD, Gregg C Fonarow, MD,

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Harvey Edward Garrett, MD, Bradley A. Wolf, MD

Michelle C. Wallace, MD, James Jaggers, MD, Jennifer S

Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J

Presentation transcript:

Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery Abhinav Goyal, MD, MHS, John H. Alexander, MD, MHS, Gail E. Hafley, MS, Stacy H. Graham, MD, Rajendra H. Mehta, MD, MS, Michael J. Mack, MD, Randall K. Wolf, MD, Lawrence H. Cohn, MD, Nicholas T. Kouchoukos, MD, Robert A. Harrington, MD, Daniel Gennevois, MD, C. Michael Gibson, MD, Robert M. Califf, MD, T. Bruce Ferguson, MD, Eric D. Peterson, MD, MPH The Annals of Thoracic Surgery Volume 83, Issue 3, Pages 993-1001 (March 2007) DOI: 10.1016/j.athoracsur.2006.10.046 Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Patient population. See Appendix for the definitions of ideal candidates for classes of evidence-based secondary prevention medications. (ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; MI = myocardial infarction; PREVENT IV = PRoject of Ex-vivo Vein graft ENgineering via Transfection IV trial.) The Annals of Thoracic Surgery 2007 83, 993-1001DOI: (10.1016/j.athoracsur.2006.10.046) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Rates of use of secondary prevention medications among postcoronary artery bypass graft surgery patients after hospital discharge and at 1 year. Rates of medication use are shown for ideal candidates for each medication class. (ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker.) The Annals of Thoracic Surgery 2007 83, 993-1001DOI: (10.1016/j.athoracsur.2006.10.046) Copyright © 2007 The Society of Thoracic Surgeons Terms and Conditions